BRANDING STRATEGIES IN THE PHARMACEUTICAL INDUSTRY VERSUS FAST MOVING CONSUMER GOODS? Abstract The objective of this paper is to analyse the branding strategies used currently in the pharmaceutical industry and compare it to the best practices in Fast Moving Consumer goods. First the authors review the differences in the way branding is defined and organised in pharmaceuticals versus FMCG and identify why branding could be leveraged in the pharmaceutical industry to help it return to strong
GLOBAL P HARMACEUTICAL I NDUSTRY : O VERVIEW & S UCCESS F ACTORS A closer look at the factors affecting growth and development ProText Knowledge Services Global Pharmaceutical Market: Overview 1. Indust ry Overview The pharmaceutical industry of the world develops and markets medicines prescribed for patients by medical practitioners. The U.S., U.K and European pharmaceutical companies are the major ones of the industry. The total number of major pharmaceutical companies (annual revenues
University of Pennsylvania ScholarlyCommons Master of Science in Organizational Dynamics Theses 5-4-2010 Organizational Dynamics Programs Problems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability Donald A. Baines University of Pennsylvania, djtz00@aol.com Submitted to the Program of Organizational Dynamics in the Graduate division of the School of Arts and Sciences in Partial Fulfillment of the Requirements for the Degree of Master of Science in the Organizational
Review:- Christine Oliver suggests that the context and process of selecting resources is an important influence on firm heterogeneity and its sustainable competitive advantage. She argued that the sustainable advantage of a firm depends on its ability managing its institutional context of resource decisions. She also suggest that both resource & institutional capital are prerequisite to sustainable competitive advantage. 3.2 Competitive Advantage is defined as possessing strong resources and capabilities
Impact of Inventory management on the profitability of Square Pharmaceuticals Ltd. 1. Introduction: Inventory is one of the factors that can control to improve business profitability. The way source and manage inventory can impact the different profit levels of income statement. Ignorance of how to use inventory advantage prevents you from maximizing operational efficiency. 2.1. Overview of the Company: SQUARE today is a name not only known in the Pharmaceutical world, it is today a
A Case Study Approach for Understanding Supply Chain Orientation in Indian Pharmaceutical Firms TOPIC AREA: OPERATIONS AND SUPPLY CHAIN MANAGEMENT Authors: Dr. J Shanmugan, Dr. Sajal Kabiraj Email: jshanmugan@skylineuniversity.com, skabiraj@skylineuniversity.com Address: Faculty Block 2, Skyline University College, P.O Box 1797, University City of Sharjah, Sharjah, UAE Tel: 06 5441155 Ext 234, 219 A Case Study Approach for Understanding Supply Chain Orientation in Indian Pharmaceutical Firms
CSR COMMUNICATION IN THE PHARMACEUTICAL INDUSTRY AN ANALYSIS OF THE WEBSITES OF THREE PHARMACEUTICAL WHOLESALERS MASTER THESIS Author: José Javier Levrino (JL82847) Supervisor: Anne Ellerup Nielsen MA in Corporate Communication Århus, Denmark. August 2010 CSR COMMUNICATION IN THE PHARMACEUTICAL INDUSTRY José Javier Levrino Table of contents Abstract 1. Introduction 1.1 Motivation 1.2 Problem statement 1.3 Delimitation 1.4 Methodology 1.4.1 1.4.2 1.4.3 1.4.4 Scientific paradigm: hermeneutics
Pharmaceuticals: Merck Sustaining Long-term Advantage Through Information Technology Hiroshi Amari Working Paper No. 161 Working Paper Series Center on Japanese Economy and Business Columbia Business School December 1998 Columbia-Yale Project: Use of Software to Achieve Competitive Advantage PHARMACEUTICALS: MERCK Sustaining Long-term Advantage Through Information Technology Prepared by Hiroshi Amari Research Associate, Yale University William V. Rapp and Hugh T. Patrick Co-principal
COURSE TITLE : “Human Resource Management” . COURSE CODE : EM-553. A Case Study On Management Development in Ciba-Geigy Ltd. (Novartis) Submitted To Professor Dr. Shahid U Ahmed Department of Management University of Dhaka Submitted By Md. Muyedul Islam ID # 3-09-16-034 Tahmina Afnan ID # 3-09-17-037 A.K.M. Majharul Huque Talukder ID # 3-09-16-021 Md. Farid Uddin ID # 3-09-16-028 Muhammad Abdul Malek ID # 3-09-16-019 Hasanuzzaman
of globalization. The number of companies and the number of countries where these companies operate and the way governments are dealing with the impacts of globalization is accelerating. The interaction of changes in government policy and business innovation has actually made globalization even faster. If a company does not become a global, it would simply be shut out of new markets. The reasons for the turmoil are numerous: a sputtering economy, increased global competition, the implementation of